These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 13399599)

  • 21. [Study of the alkaloid Rauwolfia serpentina in the treatment of hypertension].
    HERBEUVAL R; CUNY G; MANCIAUX M; GUIDAT R
    Presse Med (1893); 1954 May; 62(36):759-60. PubMed ID: 13177462
    [No Abstract]   [Full Text] [Related]  

  • 22. Cardiovascular and renal hemodynamic response to reserpine (serpasil), and clinical results of using this agent for the treatment of hypertension.
    MOYER JH
    Ann N Y Acad Sci; 1954 Apr; 59(1):82-94. PubMed ID: 13198041
    [No Abstract]   [Full Text] [Related]  

  • 23. [Comparative therapeutic effect of serpasil-ritalin combination].
    CHRISTE R
    Schweiz Med Wochenschr; 1956 Nov; 86(46):1318-21. PubMed ID: 13390870
    [No Abstract]   [Full Text] [Related]  

  • 24. Rauwolfia serpentina alkaloid in the treatment of hypertension and of certain psychopathies; critical considerations and clinical experiences.
    RICCI GC; RICORDATI M
    Rass Fisiopatol Clin Ter; 1954; 26(1-2):91-131. PubMed ID: 13204626
    [No Abstract]   [Full Text] [Related]  

  • 25. Hypotensive action of Rauwolfia serpentina alkaloid (reserpin).
    TOJA G
    Minerva Med; 1954 Dec; 45(98):1547-9. PubMed ID: 13235525
    [No Abstract]   [Full Text] [Related]  

  • 26. The cardiovascular and renal hemodynamic response to the administration of reserpine (serpasil).
    MOYER JH; HUGHES W; HUGGINS R
    Am J Med Sci; 1954 Jun; 227(6):640-8. PubMed ID: 13158349
    [No Abstract]   [Full Text] [Related]  

  • 27. Rauwolfia serpentina; prolonged use in elderly hypertensive patients.
    LIPSETT MB; LEVINE AH; GOLDMAN R
    Calif Med; 1954 Dec; 81(6):412-3. PubMed ID: 13209377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Action of rescinnamine, Rauwolfia serpentina alkdloid, on renal hemodynamics in patients with arterial hypertension].
    VERCILLO L; GIRALDI A; MOREO G
    Rass Int Clin Ter; 1961 Jan; 41():51-8. PubMed ID: 13780798
    [No Abstract]   [Full Text] [Related]  

  • 29. [Therapy of hypertension with a pure alkaloid of Rauwolfia serpentina].
    MEYER-LEDDIN H
    Med Klin; 1954 Feb; 49(8):295-8. PubMed ID: 13144246
    [No Abstract]   [Full Text] [Related]  

  • 30. [Studies of the effect of serpasil and ecolid on blood circulation in arterial hypertension].
    SPUHLER O; SCHEU H
    Cardiologia (Basel); 1957; 31(1):51-78. PubMed ID: 13446860
    [No Abstract]   [Full Text] [Related]  

  • 31. [Treatment of hypertension with serpasil].
    DZIOBA H; KOLCZYCKA Z; SZAFFMACKIEWICZ J
    Pol Tyg Lek (Wars); 1956 Jul; 11(31):1375-8. PubMed ID: 13379086
    [No Abstract]   [Full Text] [Related]  

  • 32. Rauwolfia-barbiturate-xanthine mixtures in the treatment of hypertension.
    COHEN BM
    Mil Med; 1957 Feb; 120(2):102-6. PubMed ID: 13399828
    [No Abstract]   [Full Text] [Related]  

  • 33. [Ambulatory treatment of chronic arterial hypertension with pendiomide and with serpasil-pendiomide].
    LAMBIC I
    Srp Arh Celok Lek; 1957 Mar; 85(3):343-8. PubMed ID: 13455232
    [No Abstract]   [Full Text] [Related]  

  • 34. [A potentiating effect in the treatment of arterial hypertension with Rauwolfia].
    LEUTIGER H
    Dtsch Med Wochenschr; 1956 Aug; 81(34):1361-3. PubMed ID: 13365412
    [No Abstract]   [Full Text] [Related]  

  • 35. [The effect of serpasil (reserpin, a new alkaloid from Rauwolfia serpentina B.) on isolated circulatory organs].
    TRIPOD J; MEIER R
    Arch Int Pharmacodyn Ther; 1954 Apr; 97(3-4):251-66. PubMed ID: 13171920
    [No Abstract]   [Full Text] [Related]  

  • 36. [Decrease in blood pressure after parenteral trial doses of reserpine (serpasil), hydralazine (apresolin), and pentapyrrolidin (ansolysen) in patients with arterial hypertension, with special reference to the value of the test as an indicator of the clinical effect in subsequent peroral prolonged treatment].
    KJERULF-JENSEN K; STURUP H
    Ugeskr Laeger; 1956 Oct; 118(40):1166-7. PubMed ID: 13392090
    [No Abstract]   [Full Text] [Related]  

  • 37. Cardiovascular and respiratory effects of serpasil, a new crystalline alkaloid from Rauwolfia serpentina Benth, in the dog.
    TRAPOLD JH; PLUMMER AJ; YONKMAN FF
    J Pharmacol Exp Ther; 1954 Feb; 110(2):205-14. PubMed ID: 13118494
    [No Abstract]   [Full Text] [Related]  

  • 38. [Efficacy of Rauwolfia & dihydrophthalazine preparations in hypertension].
    GRUNKE W; PREUSS EG
    Z Gesamte Inn Med; 1957 May; 12(9):414-8. PubMed ID: 13456749
    [No Abstract]   [Full Text] [Related]  

  • 39. Characterization of central effects of serpasil (reserpin, a new alkaloid of Rauwolfia serpentina B.) and of their antagonistic reactions.
    TRIPOD J; BEIN HJ; MEIER R
    Arch Int Pharmacodyn Ther; 1954 Jan; 96(3-4):406-25. PubMed ID: 13159437
    [No Abstract]   [Full Text] [Related]  

  • 40. Rauwolfia serpentina in therapy of arterial hypertension.
    RAVETTA A
    Minerva Med; 1954 Aug; 45(63-64):316-9. PubMed ID: 13203279
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.